Edition:
United States

Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

88.87USD
20 Sep 2017
Change (% chg)

-- (--)
Prev Close
$88.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,764
52-wk High
$114.63
52-wk Low
$46.81

Chart for

About

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging... (more)

Overall

Beta: 0.86
Market Cap(Mil.): $642.18
Shares Outstanding(Mil.): 7.23
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.77 16.25
EPS (TTM): -- -- --
ROI: -- 13.78 14.87
ROE: -- 16.61 13.89

BRIEF-Heska reports Q2 earnings per share $0.44

* Q2 earnings per share view $0.36 -- Thomson Reuters I/B/E/S

Jul 31 2017

BRIEF-Heska adds growth capital with $30 mln credit agreement with JPMorgan Chase

* Says credit agreement matures in July 2020 and replaces company's existing $15 million asset based line of credit

Jul 27 2017

BRIEF-Heska reports Q1 earnings per share $0.61

* Q1 earnings per share view $0.30 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

May 02 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $35.99 +0.54
Novartis AG (NOVN.S) CHF83.25 +0.35
Merck & Co., Inc. (MRK.N) $65.79 -0.16
Bayer AG (BAYGn.DE) €110.05 +0.20
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €84.03 +1.73
Eli Lilly and Co (LLY.N) $82.02 +0.29
IDEXX Laboratories, Inc. (IDXX.OQ) $158.48 --
Virbac SA (VIRB.PA) €125.05 -0.40
Vetoquinol SA (VETO.PA) €53.80 -1.40

Earnings vs. Estimates